BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19553140)

  • 1. Effects of fenoldopam mesylate on central hemodynamics and renal flow in patients undergoing cardiac surgery: color Doppler echocardiographic evaluation.
    Meco M; Cirri S
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):58-62. PubMed ID: 19553140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of various fenoldopam doses on renal perfusion in patients undergoing cardiac surgery.
    Meco M; Cirri S
    Ann Thorac Surg; 2010 Feb; 89(2):497-503. PubMed ID: 20103330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fenoldopam mesylate infusion on splanchnic perfusion after myocardial revascularization on cardiopulmonary bypass: an ultrasound Doppler study.
    Meco M; Allaz MC; Cirri S
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):642-6. PubMed ID: 21109463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fenoldopam on renal blood flow in hypertensive chronic kidney disease.
    Rovella V; Ferrannini M; Tesauro M; Marrone G; Busca A; Sorge R; Manca di Villahermosa S; Casasco M; Di Daniele N; Noce A
    J Nephrol; 2019 Feb; 32(1):75-81. PubMed ID: 29766465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of fenoldopam mesylate in preventing peak blood lactate level during cardiopulmonary bypass for paediatric cardiac surgery.
    Ressia L; Calevo MG; Lerzo F; Carleo AM; Petrucci L; Montobbio G
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):178-82. PubMed ID: 24771205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative transesophageal ultrasonography can measure renal blood flow.
    Garwood S; Davis E; Harris SN
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):65-71. PubMed ID: 11254843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenoldopam, renal hemodynamic, and cardiac surgery.
    Lema G
    Ann Thorac Surg; 2010 Sep; 90(3):1060-1; author reply 1061. PubMed ID: 20732557
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal blood flow changes induced with endothelin-1 and fenoldopam mesylate at quantitative Doppler US: initial results in a canine study.
    Sehgal CM; Arger PH; Silver AC; Patton JA; Saunders HM; Bhattacharyya A; Bell CP
    Radiology; 2001 May; 219(2):419-26. PubMed ID: 11323466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass.
    Adluri RK; Singh AV; Skoyles J; Robins A; Hitch A; Baker M; Mitchell IM
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):988-94. PubMed ID: 19406658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoldopam in newborn patients undergoing cardiopulmonary bypass: controlled clinical trial.
    Ricci Z; Stazi GV; Di Chiara L; Morelli S; Vitale V; Giorni C; Ronco C; Picardo S
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1049-53. PubMed ID: 18782787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair.
    Gilbert TB; Hasnain JU; Flinn WR; Lilly MP; Benjamin ME
    J Cardiovasc Pharmacol Ther; 2001 Jan; 6(1):31-6. PubMed ID: 11452334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs.
    Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
    Crit Care Med; 2001 Apr; 29(4):855-60. PubMed ID: 11373482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of norepinephrine and combined norepinephrine and fenoldopam infusion on systemic hemodynamics and indices of renal function in normotensive neonatal foals.
    Hollis AR; Ousey JC; Palmer L; Stephen JO; Stoneham SJ; Boston RC; Corley KT
    J Vet Intern Med; 2008; 22(5):1210-5. PubMed ID: 18638020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.
    Roasio A; Lobreglio R; Santin A; Landoni G; Verdecchia C
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):23-6. PubMed ID: 18249326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.
    Mathur VS; Swan SK; Lambrecht LJ; Anjum S; Fellmann J; McGuire D; Epstein M; Luther RR
    Crit Care Med; 1999 Sep; 27(9):1832-7. PubMed ID: 10507606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs.
    Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
    Eur J Anaesthesiol; 2000 Aug; 17(8):491-8. PubMed ID: 10998032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
    Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF
    Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenoldopam on systemic and splanchnic haemodynamics and oxygen delivery/consumption relationship during hyperdynamic ovine endotoxaemia.
    Schwieger IM; Schiffer ER; Morel DR
    Intensive Care Med; 1998 May; 24(5):509-18. PubMed ID: 9660269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.
    Bove T; Landoni G; CalabrĂ² MG; Aletti G; Marino G; Cerchierini E; Crescenzi G; Zangrillo A
    Circulation; 2005 Jun; 111(24):3230-5. PubMed ID: 15967861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.